The 1 Biotech Stock I Want to Own in 2016
This innovative biotech remains a great long-term buy this year, despite its recent volatility. Here's why.
Will 2016 Be Celgene Corporation's Best Year Yet?
Celgene outperformed the broader market in 2015, but can the company deliver superior results once more in 2016?